Chuy’s Holdings, Inc. to Participate at Two Upcoming Investor Conferences in January
Jan 06, 2016 13:30 pm UTC| Business
AUSTIN, Texas, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Chuy’s Holdings, Inc. (NASDAQ:CHUY) today announced that Steve Hislop, President and Chief Executive Officer, and Jon Howie, Vice President and Chief Financial Officer...
Capstone Secures Orders for 3.2MW of New Signature Series Microturbine Packages
Jan 06, 2016 13:30 pm UTC| Business
CHATSWORTH, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced...
Jan 06, 2016 13:30 pm UTC| Business
SAN FRANCISCO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors of the February 29, 2016 lead plaintiff deadline in the securities fraud class...
OncoMed Pharmaceuticals Appoints Perry Karsen to Board of Directors
Jan 06, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc., (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced the...
Noodles & Company to Participate at Two Upcoming Investor Conferences
Jan 06, 2016 13:30 pm UTC| Business
BROOMFIELD, Colo., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Noodles Company (NASDAQ:NDLS) today announced that it will participate at two investor conferences in January. On January 12, 2016, the Company will present at the...
CDK Global to Announce Second Quarter Fiscal 2016 Financial Results on February 3, 2016
Jan 06, 2016 13:30 pm UTC| Business
HOFFMAN ESTATES, Ill., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CDK Global, Inc. (Nasdaq:CDK) is scheduled to release its financial results for the fiscal second quarter ending December 31, 2015 before the opening of the Nasdaq...
Histogenics Corporation to Present at Biotech Showcase 2016
Jan 06, 2016 13:30 pm UTC| Business
WALTHAM, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space,...